ONXEO – Trademark Portfolio

Entity Type: 99

ONXEO holds 26 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 24 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SITAVIG and VALERIO THERAPEUTICS.

49 boulevard du Général

Martial Valin F-75015 Paris

26 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (26 results)

Trademark Classifications

ONXEO's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (24 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does ONXEO have?

ONXEO has 26 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 cancelled.

What trademark classes does ONXEO file in?

ONXEO files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ONXEO's most well-known trademarks?

ONXEO's registered trademark portfolio includes well-known marks such as SITAVIG and VALERIO THERAPEUTICS. These are among 2 currently registered trademarks in the portfolio.

What is ONXEO's trademark registration success rate?

ONXEO has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.